Combined treatment with low-dose cyclosporine and calcipotriol/ betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: A randomized controlled open-label study

Journal of Dermatological Treatment

Volumn 23, Issue 4, 2012, Pages 255-260

  Vena, Gino A ^a   Galluccio, Antonia ^b   Pezza, Michele ^b   Vestita, Michelangelo ^a   Cassano, Nicoletta ^a  

^a UNIVERSITY OF BARI   (Italy)

^b Unit of Dermatology   (Italy)

Author keywords

Calcipotriol (calcipotriene)betamethasone dipropionate; Combination therapy; Cyclosporine; Psoriasis; Two compound ointment

Indexed keywords

BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; CYCLOSPORIN A; EMOLLIENT AGENT;

ADULT; AGED; BLOOD PRESSURE ABNORMALITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG RESPONSE; DRUG SAFETY; FEMALE; HUMAN; LOW DRUG DOSE; MALE; OINTMENT; PRIORITY JOURNAL; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REVIEW; RISK BENEFIT ANALYSIS;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; BETAMETHASONE; CALCITRIOL; CYCLOSPORINE; DERMATOLOGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; OINTMENTS; PILOT PROJECTS; PSORIASIS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84863903529     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2011.565017     Document Type: Review

References (19)

1. van de Kerkhof PC. The topical treatment of psoriasis. Clin Exp Dermatol. 2005;30:205-208.
2. Fenton C, Plosker GL. Calcipotriol/betamethasone dipropionate: A review of its use in the treatment of psoriasis vulgaris. Am J Clin Dermatol. 2004;5(6):463-478.
3. Vakirlis E, Kastanis A, Ioannides D. Calcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgaris. Ther Clin Risk Manag. 2008;4(1):141-148.
4. van de Kerkhof PC, Wasel N, Kragballe K, Cambazard F, Murray S. A two-compound product containing calcipotriol and betamethasone dipropionate provides rapid, effective treatment of psoriasis vulgaris regardless of baseline disease severity. Dermatology. 2005;210(4):294-299.
5. Kragballe K, Austad J, Barnes L, Bibby A, de la Brassinne M, Cambazard F, et al. Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/ Taclonex) in the treatment of psoriasis vulgaris. Dermatology. 2006;213(4):319-326.
6. Berth-Jones J. The use of ciclosporin in psoriasis. J Dermatol Treat. 2005;16(5-6):258-277.
7. Griffiths CE, Katsambas A, Dijkmans BA, Finlay AY, Ho VC, Johnston A, et al. Update on the use of ciclosporin in immune- mediated dermatoses. Br J Dermatol. 2006;155(Suppl 2): 1-16.
8. Ho VC, Griffiths CE, Albrecht G, Vanaclocha F, León-Dorantes G, Atakan N, et al. Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: A 1-year multicentre, randomized study. The PISCES Study Group. Br J Dermatol. 1999;141(2): 283-291.
9. Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica. 1978;157(4):238-244.
10. Douglas WS, Poulin Y, Decroix J, Ortonne JP, Mrowietz U, Gulliver W, et al. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Acta Derm Venereol. 2002;82(2):131-135.
11. Kaufmann R, Bibby AJ, Bissonnette R, Cambazard F, Chu AC, Decroix J, et al. A new calcipotriol/betamethasone dipropionate (Daivobet) is an effective once daily treatment for psoriasis vulgaris. Dermatology. 2002;205(4):389-393.
12. Guenther L, van de Kerkhof PC, Snellman E, Kragballe K, Chu AC, Tegner E, et al. Efficacy and safety of a new combination of calcipotriol and betamethasone (once or twice daily) compared with calcipotriol (twice daily) in the treatment of psoriasis vulgaris: aA randomised, double blind, vehiclecontrolled trial. Br J Dermatol. 2002;147(2):316-323.
13. Papp KA, Guenther L, Boyden B, Larsen FG, Harvima RJ, Guilhou JJ, et al. Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. J Am Acad Dermatol. 2003;48 (1):48-54.
14. Kragballe K, van de Kerkhof PC. Consistency of data in six phase III clinical studies of a two-compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasis. J Eur Acad Dermatol Venereol. 2006;20(1):39-44.
15. Anstey AV, Kragballe K. Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/ betamethasone dipropionate ointment. Int J Dermatol. 2006;45(8):970-975.
16. Van de Kerkhof PCM. Therapeutic strategies: Rotational therapy and combinations. Clin Exp Dermatol. 2001;26(4): 356-361.
17. Lebwohl M, Menter A, Koo J, Feldman SR. Combination therapy to treat moderate to severe psoriasis. J Am Acad Dermatol. 2004;50(3):416-430.
18. Cassano N, Colombo D, Vena GA. Linee guida al trattamento della psoriasi con ciclosporina A. G Ital Dermatol Venereol. 2001;136(6):463-470.
19. Grossman RM, Thivolet J, Claudy A, Souteyrand P, Guilhou JJ, Thomas P, et al. A novel therapeutic approach to psoriasis with combination calcipotriol ointment and very low-dose cyclosporine: Results of a multicenter placebocontrolled study. J Am Acad Dermatol. 1994;31(1):68-74.